TP53 and pulmonary fibrosis: CSP7 treatment significantly reduces ECM proteins such as collagen in mouse lung homogenate and reduces fibrosis as measured by micro-CT scan and trichrome staining by targeting the p53 master switch at the level of upstream signaling to increase the viability of injured AECs, prevents expansion of fLfs and reverses as well as prevents pulmonary fibrosis.